A1CD
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PRODUCTOS ROCHE, S.A. DE C.V.·Registered July 16, 2019EL REACTIVO HEMOLIZANTE SE USA EN LOS SISTEMAS ROCHE PARA DILUIR EL TEST TINA-QUANT HEMOGLOBIN A1C GEN 3. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETES.
THE HEMOLYSING REAGENT IS USED IN ROCHE SYSTEMS TO DILUTE THE TINA-QUANT HEMOGLOBIN A1C GEN 3 TEST. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO HEMOLIZANTE
- Trade Name (English)
- HEMOLIZING REAGENT
- Analysis ID
- 1343R2019 SSA
- Registration Date
- July 16, 2019
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for A1CD (A1CD) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1343R2019 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on July 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.